BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15298951)

  • 21. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages.
    Shin A; Shu XO; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1567-70. PubMed ID: 15941974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
    Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An association between a NQO1 genetic polymorphism and risk of lung cancer.
    Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
    Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
    Long JR; Egan KM; Dunning L; Shu XO; Cai Q; Cai H; Dai Q; Holtzman J; Gao YT; Zheng W
    Pharmacogenet Genomics; 2006 Apr; 16(4):237-43. PubMed ID: 16538170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
    van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
    Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.
    Li H; Feng L; Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Li J; Xie Y
    Acta Oncol; 2006; 45(5):597-601. PubMed ID: 16864175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
    Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
    Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
    Shen Y; Li DK; Wu J; Zhang Z; Gao E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.
    Metsola K; Kataja V; Sillanpää P; Siivola P; Heikinheimo L; Eskelinen M; Kosma VM; Uusitupa M; Hirvonen A
    Breast Cancer Res; 2005; 7(6):R987-97. PubMed ID: 16280050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study.
    Bock CH; Wenzlaff AS; Cote ML; Land SJ; Schwartz AG
    Carcinogenesis; 2005 Feb; 26(2):381-6. PubMed ID: 15498787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
    Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
    Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
    Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
    Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Kang D; Vainio H; Uusitupa M; Hirvonen A
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):635-40. PubMed ID: 11401913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women.
    Okobia M; Bunker C; Zmuda J; Kammerer C; Vogel V; Uche E; Anyanwu S; Ezeome E; Ferrell R; Kuller L
    Breast Cancer Res Treat; 2005 Dec; 94(3):285-93. PubMed ID: 16254684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
    Kotsopoulos J; Ghadirian P; El-Sohemy A; Lynch HT; Snyder C; Daly M; Domchek S; Randall S; Karlan B; Zhang P; Zhang S; Sun P; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):912-6. PubMed ID: 17507615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
    Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women.
    Boyapati SM; Shu XO; Gao YT; Cai Q; Jin F; Zheng W
    Cancer; 2005 Jun; 103(11):2228-35. PubMed ID: 15856430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbohydrates and the risk of breast cancer among Mexican women.
    Romieu I; Lazcano-Ponce E; Sanchez-Zamorano LM; Willett W; Hernandez-Avila M
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1283-9. PubMed ID: 15298947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
    Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.